ADC Therapeutics SA - 8-K Filing
ADC Therapeutics announces ZYNLONTA clinical data updates for ASH Annual Meeting including LOTIS-7 Phase 1b and MZL Phase 2 results. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $ADCT